This role is listed by an employer that holds a live Home Office sponsor licence on the Skilled Worker route.
NHS roles fall under the Health and Care Worker route. Salaries set by national pay scales (NHS bands) at or above the relevant band rate typically meet the occupation's requirement.
Individual eligibility depends on personal circumstances. These figures are public reference information, not advice or a verdict on this job.
Job summary
PENDING RC APPROVAL
This Oncology Consultant post will be based at University Hospitals Coventry and Warwickshire NHS Trust (UHCW and South Warwickshire University Foundation Trust (SWUFT). The appointee will work in site specific local and specialist MDTs at UHCW and SWUFT.
The appointee will work with site specific local and specialist MDTs for Head and Neck cancers at UHCW and Breast cancers at SWUFT. The typical new patient caseload is expected to be on average 5 per week in a 10PA job plan, and up to 210 per annum based on 42 working weeks of routine work (excluding leave and on-call).
The role is supported by a dedicated CNS team. You will be expected to support the Acute Oncology Service and the Oncology ward in-patient care, as necessary on working days. Patients will be treated in the Arden Cancer Centre on the UHCW site and Rugby St. Cross Hospital. SWUFT patients are treated in the Aylesford unit at Warwick hospital and the Rigby unit at Stratford hospital.
Main duties of the job
The post is required to support the site-specialist consultant led service including facilities for inpatients and outpatients, a dedicated chemotherapy suite and radiotherapy facilities. In addition, there is an integrated Oncology Clinical Trials Centre and the department is currently developing its Medical Oncology team. The post holder will be expected to provide cross cover for MDTs (videoconferencing is available) and to liaise with the Acute Physicians/Emergency department as part of the supporting the Acute Nurse Led Oncology Service.
You will be joining a team of 22 Clinical Oncologists and 4 Medical Oncologists at UHCW Cancer Centre, serving UHCW and the adjoining Cancer Units at South Warwickshire University NHS Foundation Trust (SWUFT), George Eliot Hospital (GEH), Stratford Rigby Unit and Rugby Maple Unit.
About us
University Hospitals Coventry and Warwickshire NHS Trust, rated as good by the Care Quality Commission, is one of the largest teaching Trusts in the UK.
We are extremely proud of our employees across our hospital sites, with high quality patient care at the heart of everything we do.
Boasting some of the most modern facilities in Western Europe, the Trust is renowned for being at the forefront of research and innovation as part of its blossoming reputation as a worldwide leader in healthcare.
We are proud to be recognised as a Pathway to Excellence designated organisation - please click the link for further details about this prestigious award. Pathway To Excellence - University Hospitals Coventry & Warwickshire (uhcw.nhs.uk)
By joining our exciting journey, you will form part of a passionate, talented team and will be able to access a wide range of learning and development opportunities. There has never been a better time to join our team.
The Trust is committed to building an organisation that makes full use of the talents, skills, experience, and different perspectives available in our diverse society. We want everyone to feel they are respected, valued, can achieve their potential and receive the most appropriate and relevant care. We will create an environment where the equality and human rights principles of fairness, respect, equality, dignity and autonomy are promoted and are part of the organisation's core values.
Details
Date posted
24 September 2026
Pay scheme
Hospital medical and dental staff
Grade
Consultant
Salary
£113,565 to £150,569 a year per annum
Contract
Permanent
Working pattern
Full-time
Reference number
218-T2-SCT-8320433
Job locations
UHCW
Clifford Bridge Road
Coventry
CV2 2DX
United Kingdom
Similar sponsored roles
All rolesLast verified against our ingestion on 29 September 2026; sponsor register dataset 2026-09-25.